Literature DB >> 7876085

Characterization and comparison of the interleukin 13 receptor with the interleukin 4 receptor on several cell types.

N Vita1, S Lefort, P Laurent, D Caput, P Ferrara.   

Abstract

We describe here the characterization of the interleukin (IL) 13 receptor and a comparison with the IL-4 receptor on different cell types. Several, but not all, of the IL-4 receptor-positive cells showed specific IL-13 binding, which was always completely displaced by IL-4. In the IL-13 receptor-positive cells, the IL-13 either completely or partially displaced the labeled IL-4. Further characterization of the IL-13 receptor in two cell lines, COS-3 and A431, representative of the groups of complete and partial displacement of IL-4 by IL-13, respectively, showed that the IL-13 binds with high affinity (Kd approximately 300 pM) to both cells and that the number of binding sites is, in COS-3 cells, equivalent to that for IL-4 and, in A431 cells, is smaller than that for IL-4. Cross-linking of labeled IL-13 yielded, on COS-3 cells, two affinity-labeled complexes of 220 and 70 kDa, and on A431 cells, one complex of 70 kDa; labeled IL-4 yielded on both cells the same pattern of three complexes of 220, 145, and 70 kDa. Altogether, these results suggest that the IL-13 receptor may be constituted by a subset of the IL-4 receptor complex associated with at least one additional protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876085     DOI: 10.1074/jbc.270.8.3512

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Interleukin-4 receptor expression on AIDS-associated Kaposi's sarcoma cells and their targeting by a chimeric protein comprised of circularly permuted interleukin-4 and Pseudomonas exotoxin.

Authors:  S R Husain; P Gill; R J Kreitman; I Pastan; R K Puri
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

2.  Regulation of 15-lipoxygenase expression in lung epithelial cells by interleukin-4.

Authors:  R Brinckmann; M S Topp; I Zalán; D Heydeck; P Ludwig; H Kühn; W E Berdel; J R Habenicht
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

3.  IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain.

Authors:  R L Palmer-Crocker; C C Hughes; J S Pober
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

4.  Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma.

Authors:  C Doucet; D Brouty-Boyé; C Pottin-Clémenceau; G W Canonica; C Jasmin; B Azzarone
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

5.  Interleukin-13 selectively induces monocyte chemoattractant protein-1 synthesis and secretion by human endothelial cells. Involvement of IL-4R alpha and Stat6 phosphorylation.

Authors:  M Goebeler; B Schnarr; A Toksoy; M Kunz; E B Bröcker; A Duschl; R Gillitzer
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

6.  Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha.

Authors:  M G Malabarba; H Rui; H H Deutsch; J Chung; F S Kalthoff; W L Farrar; R A Kirken
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

Review 7.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

8.  Molecular cloning of the rat IL-13 alpha 2 receptor cDNA and its expression in rat tissues.

Authors:  An-Hua Wu; Walter C Low
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

9.  Growth inhibition signalled through the interleukin-4/interleukin-13 receptor complex is associated with tyrosine phosphorylation of insulin receptor substrate-1.

Authors:  B Schnyder; H Lahm; G Woerly; N Odartchenko; B Ryffel; B D Car
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

10.  Bcl-3 acts as an innate immune modulator by controlling antimicrobial responses in keratinocytes.

Authors:  Amanda S Büchau; Daniel T MacLeod; Shin Morizane; Paul F Kotol; Tissa Hata; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2009-03-12       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.